This is the first study to report the rotational stability of the AcrySof SA60TT toric IOL in a series of 44 cases 3 months after implantation in cataract surgery. In this series, the largest rotation ...
To compare AcrySof toric intraocular lens (IOL) and non-toric IOL in patients who had combined 23-gauge microincisional vitrectomy surgery (MIVS) and phacoemulsification for vitreoretinal diseases and ...
Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof ® IQ PanOptix ® Toric presbyopia- and astigmatism-correcting ...
Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — A toric IOL for use in cataract patients with existing astigmatism has been granted U.S.
Two human cadaver eyes were prepared in accordance with the Miyake–Apple technique, with closed-system modification. After phacoemulsification, an Acrysof Toric IOL was implanted in the capsular bag.
Please provide your email address to receive an email when new articles are posted on . NEW YORK — The AcrySof Toric IOL can “significantly reduce” cylinder and improve uncorrected visual acuity in ...
Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with ...
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Background: To evaluate the rotational stability of the three types of AcrySof SA60TT toric intraocular lenses (Alcon, Switzerland) in cataract surgery after the first postoperative week. Methods: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results